Comparative Analysis of CRISPR-Cas9, Lentiviral Transduction, and Base Editing for Sickle Cell Disease in a Murine Model

The authors optimized ex vivo conditions in CD34⁺ hematopoietic stem and progenitor cells (HSPCs) and infused edited sickle cell disease HSPCs into busulfan-conditioned NBSGW mice.